Immunovia AB (publ) (IMMNOV.ST) Research

Immunovia AB (publ) is a diagnostics company focused on developing and marketing blood tests, serving both Swedish and international markets. Its key offering is IMMray PanCan-d, a specialized blood test designed to facilitate the early diagnosis of pancreatic cancer. The company also pursues research initiatives concerning lung cancer. Established in 2007, Immunovia's main office is located in Lund, Sweden.

Market snapshot

Symbol
IMMNOV.ST
Price
$0.19
Day change
+1.05%
Market cap
$65.7M
P/E ratio
-0.69x
52-week range
0.1502-0.75266
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Next earnings
in 2 months

Peer companies

  • Active Biotech AB (publ) (ACTI.ST)
  • Biovica International AB (publ) (BIOVIC-B.ST)
  • Scandinavian Real Heart AB (Publ) (HEART.ST)
  • Iconovo AB (publ) (ICO.ST)
  • IDL Diagnostics AB (publ) (IDLDX.ST)
  • Luxbright AB (publ) (LXB.ST)
  • NextCell Pharma AB (NXTCL.ST)
  • Pila Pharma AB (publ) (PILA.ST)

Open Immunovia AB (publ) (IMMNOV.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.